Holen Sie sich die Stockscreener-App
2.99
0.34%
0.01
Handel nachbörslich:
2.99
Schlusskurs vom Vortag:
$2.98
Offen:
$2.98
24-Stunden-Volumen:
117.50K
Relative Volume:
0.47
Marktkapitalisierung:
$58.32M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.15M
KGV:
-0.7475
EPS:
-4
Netto-Cashflow:
$-21.66M
1W Leistung:
-3.86%
1M Leistung:
-8.28%
6M Leistung:
-14.08%
1J Leistung:
+27.78%
1-Tages-Spanne:
$2.96
$3.06
1-Wochen-Bereich:
$2.89
$3.165
52-Wochen-Spanne:
$1.10
$6.01
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Firmenname
Nrx Pharmaceuticals Inc
Sektor
Branche
Telefon
484-254-6134
Adresse
1201 ORANGE STREET, WILMINGTON
Vergleichen Sie NRXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
2.99 | 60.66M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-02 | Eingeleitet | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten
What analysts say about NRx Pharmaceuticals Inc. stockBreakout stock performance - jammulinksnews.com
NRx Pharmaceuticals Inc. Equity Warrant Stock Analysis and ForecastRapidly growing investment returns - jammulinksnews.com
NRx Pharmaceuticals Inc. Stock Analysis and ForecastFree Trend-Following Techniques - Autocar Professional
Is NRx Pharmaceuticals Inc. Equity Warrant a good long term investmentConsistent high-performance stocks - Autocar Professional
What drives NRx Pharmaceuticals Inc. Equity Warrant stock priceConsistently superior profits - jammulinksnews.com
What drives NRx Pharmaceuticals Inc. stock priceBreakout stock performance - jammulinksnews.com
What analysts say about NRx Pharmaceuticals Inc. Equity Warrant stockFree High-Return Strategy Alerts - jammulinksnews.com
NRx Pharmaceuticals' Dual-Path Strategy for NRX-100: A Game-Changer in Suicidal Depression Treatment - AInvest
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Charts Dual-Path for NRX-100 - Yahoo Finance
NRx Pharmaceuticals (NASDAQ: NRXP) Charts Dual-Path for NRX-100 - TipRanks
Is NRx Pharmaceuticals Inc. a good long term investmentBreakthrough profits - Autocar Professional
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
NRx Pharmaceuticals (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment - The Globe and Mail
NRx Pharmaceuticals: Pioneering Mental Health Innovation Through Clinical and Operational Synergy - AInvest
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment - Yahoo Finance
NRx Pharmaceuticals (NASDAQ: NRXP) Positioning At The Forefront Of Next-Gen Treatment - Barchart.com
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic - The Globe and Mail
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic - Yahoo Finance
Nrx Pharmaceuticals shares rise 1.23% after-hours after being added to Russell Microcap Growth Index. - AInvest
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Agreement to Acquire Interest in Cohen and Associates, LLC for HOPE's Network of Interventional Psychiatry Clinics - Eastern Progress
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire 49% Stake in Leading Florida Psychiatry Clinic - The Globe and Mail
IBN Initiates Coverage of NRx Pharmaceuticals Inc. - GlobeNewswire
NRXP: Analyst Maintains 'Buy' Rating with Target Price Firm at $31 | NRXP Stock News - GuruFocus
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100) - Nasdaq
New FDA Fast-Track Program Could Accelerate Ketamine Depression Drug Approval by 10 Months - Stock Titan
New to The Street Show #673 Airs Nationwide on Bloomberg TVSaturday, June 21 at 6:30 PM EST Featuring FLOKI, NRX Pharmaceuticals (NASDAQ:NRXP), MUSQThe Music ETF (NYSE:MUSQ), Health In Tech (NASDAQ:HIT), and Vita Bella - Detroit Free Press
New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST - The Joplin Globe
NRx Pharmaceuticals (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners - financial-news.co.uk
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners - StreetInsider
NRx Pharmaceuticals Taps Top Biotech IR Firm ahead of Critical FDA Filings and Clinic Acquisitions - Stock Titan
New to The Street Episode #671 Airs Tonight on Bloomberg Television at 6:30 PM EST Featuring FLOKI, Arrive AI (NASDAQ: ARAI), Health In Tech (NASDAQ: HIT), Vita Bella, and NRX Pharmaceuticals (NASDAQ: NRXP) - Livingston Daily
NRX Pharmaceuticals: A Promising Investment with Innovative Growth and Strong Financial Outlook - TipRanks
Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):